Executive record
Jeffrey Rona
Most recent record: Ovid Therapeutics Inc. CFO transition: Charles Carter to succeed Jeffrey Rona (named as the outgoing officer), effective July 6, 2026.
2 verified records · 1 company
Career line from the records
2Each seat as a filing states it, newest first. Titles appear only as the filing prints them for this person.
2026-07-08TransitionOvid Therapeutics Inc.
Ovid Therapeutics Inc. CFO transition: Charles Carter to succeed Jeffrey RonaNamed as the outgoing officer
effective July 6, 2026 · 8-K filed July 8, 2026 · sec.gov, Item 5.02
2026-03-1810-K signatureOvid Therapeutics Inc.
Signed the annual report as Chief Business and Financial Officer (Principal Financial and Accounting Officer)
10-K filed March 18, 2026 · sec.gov
Companies
1This page lists only verified filing records that name Jeffrey Rona, matched by the name as the filings print it; it is not a career history. Corrections: the corrections page.